IL2‐mediated modulation of small extracellular vesicles secretion and PD‐L1 expression: a novel perspective for neutralizing immune suppression within cancer cells
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Cancer communications. - 44, 12 (2024) , 1422-1426, ISSN: 2523-3548
- Ereignis
-
Veröffentlichung
- (wo)
-
Freiburg
- (wer)
-
Universität
- (wann)
-
2024
- Urheber
-
Noh, Soojeong
Ryu, Suyeon
Jung, Dokyung
Shin, Sanghee
Jung, Inseong
Kang, Sung‐Min
Kim, Christine Seulki
Choi, Sung‐Jin
Cho, Hanchae
Schwämmle, Melanie
Jeong, Youngtae
Bucher, Felicitas
Choi, Il‐Kyu
Lee, Shin Yup
Im, Sin‐Hyeog
Yea, Kyungmoo
Baek, Moon-Chang
- DOI
-
10.1002/cac2.12623
- URN
-
urn:nbn:de:bsz:25-freidok-2586202
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:36 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Noh, Soojeong
- Ryu, Suyeon
- Jung, Dokyung
- Shin, Sanghee
- Jung, Inseong
- Kang, Sung‐Min
- Kim, Christine Seulki
- Choi, Sung‐Jin
- Cho, Hanchae
- Schwämmle, Melanie
- Jeong, Youngtae
- Bucher, Felicitas
- Choi, Il‐Kyu
- Lee, Shin Yup
- Im, Sin‐Hyeog
- Yea, Kyungmoo
- Baek, Moon-Chang
- Universität
Entstanden
- 2024
Ähnliche Objekte (12)
The Regulation of PD-L1 Secretion in Extracellular Vesicles by Melanoma Cells
Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors
Tumor-derived small extracellular vesicles promote breast cancer progression by upregulating PD-L1 expression in macrophages
PD-L1 Expression als Prognosemarker beim Endometriumkarzinom
Factors correlating the expression of PD-L1
Optimized PD-L1 scoring of gastric cancer
Prognostic value of soluble PD-L1 and exosomal PD-L1 in advanced gastric cancer patients receiving systemic chemotherapy
Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation
Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway
Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?
PD-L1 Expression in malignen Melanomen der Vulva
The Regulation of PD-L1 Secretion in Extracellular Vesicles by Melanoma Cells
Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors
Tumor-derived small extracellular vesicles promote breast cancer progression by upregulating PD-L1 expression in macrophages
PD-L1 Expression als Prognosemarker beim Endometriumkarzinom
Factors correlating the expression of PD-L1
Optimized PD-L1 scoring of gastric cancer
Prognostic value of soluble PD-L1 and exosomal PD-L1 in advanced gastric cancer patients receiving systemic chemotherapy
Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation
Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway
Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?
PD-L1 Expression in malignen Melanomen der Vulva
The Regulation of PD-L1 Secretion in Extracellular Vesicles by Melanoma Cells
Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors
Tumor-derived small extracellular vesicles promote breast cancer progression by upregulating PD-L1 expression in macrophages
PD-L1 Expression als Prognosemarker beim Endometriumkarzinom
Factors correlating the expression of PD-L1
Optimized PD-L1 scoring of gastric cancer
Prognostic value of soluble PD-L1 and exosomal PD-L1 in advanced gastric cancer patients receiving systemic chemotherapy
Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation
Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway
Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?